Drug Screening Market Analysis

Market Insights

The drug screening market is estimated to grow from USD 5.24 billion in 2021 to USD 15.52 billion by 2028 at a healthy CAGR of 16.74% during the forecast period.

Wish to get a free sample? Click here.

What is drug screening?

Drug screening is defined as the process of collecting and analyzing blood, hair, urine, or saliva to detect the presence of contaminants and chemicals left in the body as a result of drug consumption. In this process, potential drugs are identified and optimized before selecting a candidate drug for a clinical trial. Drug screening is done in order to determine if a person is or has consumed drugs at a certain point in time.

COVID-19 Impact on Drug Screening Market

The covid-19 outbreak affected the growth of the drug screening market for a short period of time due to disruption in business and economic activities across geographies. Postponement of non-essential medical services amid the covid-19 outbreak also affected the growth of the drug screening market. However, with the reopening of the economy, the market is likely to experience growth during the review period.

Market Dynamics

Increasing drug and alcohol testing measures in various countries to curb the menace of drug and alcohol abuse is likely to drive market growth significantly.

• The market growth is primarily driven by an increase in the consumption of drugs and alcohol across the geographies, particularly among the youth and elder population.
• The players operating in the market are emphasizing product innovation to strengthen their market presence and attain a competitive edge over other market players.

Want to have a closer look at this report, Download a free sample

Key Players

Key players operating in the drug screening market are-

• Alere Inc. (The U.S),
• Laboratory Corporation of America Holdings (The U.S),
• OraSure Technologies (The U.S),
• Quest Diagnostics (The U.S),
• Thermo Fisher Scientific (The U.S),
• Alfa Scientific Designs, Inc. (The U.S),
• MPD Inc. (The U.S),
• Lifeloc Technologies, Inc. (The U.S),
• Omega Laboratories Inc. (The U.S),
• Sciteck Diagnostics Inc (The U.S),
• ACM GLOBAL LABORATORIES (The U.S), and
• Carehealth America Corporation (The U.S).

Segment Analysis

End User Trends

The workplace segment accounted for the largest market share in 2021.

Based on end users, the market has been divided into workplace, criminal justice systems and law enforcement agencies, drug treatment centers, pain management centers, drug testing laboratories, and others. The segment growth can be attributed to a rising safety concern for the staff.

Regional Trends

The market in North America accounted for the largest share in 2021 due to the high consumption of drugs and alcohol. Additionally, supporting government measures to curb the use of drugs is likely to add significantly to the market growth. The market in Europe accounted for the second-largest market share in 2021.

Want to know which region offers the best growth opportunities then, Click Here.

Critical Questions answered in this report-

• What are the key trends in the drug screening market?
• How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
• What is the impact of COVID-19 on the drug screening market?
• What are the key strategies adopted by the major vendors to lead in the drug screening market?
• What is the market share of the top vendors?

Target Audience

Here is the list of the group of customers that the Drug Screening Market hopes to have the greatest opportunity to convert-

• Drug screening distributors
• Drug screening suppliers
• Drug screening manufacturers
• Logistics organizations
• Government Bodies

Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.